Literature DB >> 2025983

Retrograde spread of mesalazine (5-aminosalicylic acid)-containing enema in patients with ulcerative colitis.

M M Tiel-van Buul1, C J Mulder, E A van Royen, E H Wiltink, G N Tytgat.   

Abstract

In order to investigate the retrograde spread in the colon and its relationship to the extent of the diseased area, the authors evaluated a 100ml enema of mesalazine (5-aminosalicylic acid, Pentasa') lg in a consecutive series of 30 patients with ulcerative colitis. The enema was labelled with 10 MBq 99mtechnetium-human serum albumin microcolloid. Sequential scintigraphic imaging was performed in all patients, and the results compared with the extension of the disease as found by colonoscopy. If the enema reached the entire affected area it was interpreted as 'topically adequate'. In 80% of the patients there was retrograde spread of the enema beyond the rectosigmoid, thus reaching the affected area in ulcerative colitis. No relationship was found between the extent of dispersion of the enema and the time of defecation prior to scintigraphy. The authors conclude that a 100ml 'Pentasa' enema may be adequate for treatment of ulcerative colitis extending up to the splenic flexure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2025983     DOI: 10.2165/00003088-199120030-00006

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  10 in total

1.  Spread of steroid-containing foam after intrarectal administration.

Authors:  D J Hay; H Sharma; M H Irving
Journal:  Br Med J       Date:  1979-06-30

2.  Enema volume as an important factor in successful topical corticosteroid treatment of colitis.

Authors:  E T Swarbrick; H Loose; J E Lennard-Jones
Journal:  Proc R Soc Med       Date:  1974-08

3.  Retrograde spread of 5-aminosalicylic acid enemas in patients with active ulcerative colitis.

Authors:  M Campieri; G A Lanfranchi; C Brignola; G Bazzocchi; P Gionchetti; M R Minguzzi; I P Cappello; C Corbelli; S Boschi
Journal:  Dis Colon Rectum       Date:  1986-02       Impact factor: 4.585

4.  Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas.

Authors:  M Campieri; G A Lanfranchi; G Bazzocchi; C Brignola; F Sarti; G Franzin; A Battocchia; G Labo; P R Dal Monte
Journal:  Lancet       Date:  1981-08-08       Impact factor: 79.321

5.  Retrograde spread of hydrocortisone containing foam given intrarectally in ulcerative colitis.

Authors:  M J Farthing; M D Rutland; M L Clark
Journal:  Br Med J       Date:  1979-10-06

6.  Comparison of 5-aminosalicylic acid (3 g) and prednisolone phosphate sodium enemas (30 mg) in the treatment of distal ulcerative colitis. A prospective, randomized, double-blind trial.

Authors:  C J Mulder; G N Tytgat; E H Wiltink; H J Houthoff
Journal:  Scand J Gastroenterol       Date:  1988-10       Impact factor: 2.423

7.  Retrograde spread of therapeutic enemas in patients with inflammatory bowel disease.

Authors:  M M van Buul; C J Mulder; E H Wiltink; E A van Royen; G N Tytgat
Journal:  Hepatogastroenterology       Date:  1989-08

8.  Topical 5-aminosalicylic acid versus prednisolone in ulcerative proctosigmoiditis. A randomized, double-blind multicenter trial. Danish 5-ASA Group.

Authors: 
Journal:  Dig Dis Sci       Date:  1987-06       Impact factor: 3.199

9.  Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.

Authors:  P A van Hees; J H Bakker; J H van Tongeren
Journal:  Gut       Date:  1980-07       Impact factor: 23.059

10.  An experiment to determine the active therapeutic moiety of sulphasalazine.

Authors:  A K Azad Khan; J Piris; S C Truelove
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

  10 in total
  4 in total

Review 1.  Pharmacokinetics of rectal drug administration, Part II. Clinical applications of peripherally acting drugs, and conclusions.

Authors:  E J van Hoogdalem; A G de Boer; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

Review 2.  [Pharmacokinetic data for different 5-aminosalicylic acid and budesonide preparations].

Authors:  U Klotz
Journal:  Med Klin (Munich)       Date:  1999-02-15

3.  Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis.

Authors:  J K Marshall; E J Irvine
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

4.  Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis. A multicenter comparative trial with 5-ASA enema.

Authors:  M Campieri; P Paoluzi; G D'Albasio; G Brunetti; A Pera; L Barbara
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.